Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1957 1
1958 1
1959 5
1960 7
1961 15
1962 10
1963 8
1964 37
1965 31
1966 51
1967 72
1968 51
1969 87
1970 87
1971 108
1972 74
1973 105
1974 139
1975 165
1976 159
1977 204
1978 173
1979 174
1980 161
1981 151
1982 170
1983 176
1984 214
1985 188
1986 207
1987 254
1988 286
1989 401
1990 391
1991 420
1992 493
1993 501
1994 552
1995 592
1996 572
1997 669
1998 618
1999 607
2000 702
2001 724
2002 783
2003 765
2004 774
2005 888
2006 910
2007 914
2008 966
2009 924
2010 1072
2011 1153
2012 1167
2013 1124
2014 1228
2015 1309
2016 1217
2017 1296
2018 1330
2019 1273
2020 1355
2021 1401
2022 1338
2023 1281
2024 404

Text availability

Article attribute

Article type

Publication date

Search Results

32,755 results

Results by year

Filters applied: . Clear all
Page 1
Early Detection and Screening for Breast Cancer.
Coleman C. Coleman C. Semin Oncol Nurs. 2017 May;33(2):141-155. doi: 10.1016/j.soncn.2017.02.009. Epub 2017 Mar 29. Semin Oncol Nurs. 2017. PMID: 28365057 Review.
OBJECTIVE: To review the history, current status, and future trends related to breast cancer screening. DATA SOURCES: Peer-reviewed articles, web sites, and textbooks. CONCLUSION: Breast cancer remains a complex, heterogeneous disease. Serial …
OBJECTIVE: To review the history, current status, and future trends related to breast cancer screening. DATA SOURCES: P …
Screening for breast cancer in 2018-what should we be doing today?
Seely JM, Alhassan T. Seely JM, et al. Curr Oncol. 2018 Jun;25(Suppl 1):S115-S124. doi: 10.3747/co.25.3770. Epub 2018 Jun 13. Curr Oncol. 2018. PMID: 29910654 Free PMC article. Review.
For women 40-74 years of age who actually participate in screening every 1-2 years, breast cancer mortality is reduced by 40%. ...An important limitation of screening is the false negatives (15%-20%). The technologic advances of digital breast t …
For women 40-74 years of age who actually participate in screening every 1-2 years, breast cancer mortality is reduced …
Screening for Breast Cancer.
Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Niell BL, et al. Radiol Clin North Am. 2017 Nov;55(6):1145-1162. doi: 10.1016/j.rcl.2017.06.004. Radiol Clin North Am. 2017. PMID: 28991557 Review.
The goal of screening is to detect breast cancers when still curable to decrease breast cancer-specific mortality. Breast cancer screening in the United States is routinely performed with mammography, supplemental digital …
The goal of screening is to detect breast cancers when still curable to decrease breast cancer-specific mortalit …
Breast Cancer Screening, Mammography, and Other Modalities.
Fiorica JV. Fiorica JV. Clin Obstet Gynecol. 2016 Dec;59(4):688-709. doi: 10.1097/GRF.0000000000000246. Clin Obstet Gynecol. 2016. PMID: 27741212 Review.
This article is an overview of the modalities available for breast cancer screening. The modalities discussed include digital mammography, digital breast tomosynthesis, breast ultrasonography, magnetic resonance imaging, and clinical b
This article is an overview of the modalities available for breast cancer screening. The modalities discussed include d …
Breast cancer screening: a dividing controversy.
Khrouf S, Letaief Ksontini F, Ayadi M, Belhaj Ali Rais H, Mezlini A. Khrouf S, et al. Tunis Med. 2020 Jan;98(1):22-34. Tunis Med. 2020. PMID: 32395774 Free article. Review.
RESULTS: We reviewed 36 articles published between 2001 and 2018 assessing the benefit of breast cancer screening. The mortality reduction due to breast cancer screening is estimated between 15-30% by the randomized trials. However, overd …
RESULTS: We reviewed 36 articles published between 2001 and 2018 assessing the benefit of breast cancer screening. The …
Breast cancer screening in young women.
Desreux JAC. Desreux JAC. Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:208-211. doi: 10.1016/j.ejogrb.2018.05.018. Epub 2018 May 24. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29804884 Review.
Breast cancer is the leading cause of death by cancer in women aged less than 40. ...Individualized screening, targeting only some young high-risk women, may be beneficial although no randomized trial has proven an impact on breast cancer
Breast cancer is the leading cause of death by cancer in women aged less than 40. ...Individualized screening, t
Breast cancer screening in average and high-risk women.
Rahman WT, Helvie MA. Rahman WT, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Sep;83:3-14. doi: 10.1016/j.bpobgyn.2021.11.007. Epub 2021 Nov 19. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 34903436 Review.
Breast cancer is the most common cancer among females worldwide with rising incidence. ...Pregnant and lactating patients at average risk for breast cancer are recommended to undergo age-appropriate screening mammography....
Breast cancer is the most common cancer among females worldwide with rising incidence. ...Pregnant and lactating patien
Breast cancer screening in developing countries.
da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. da Costa Vieira RA, et al. Clinics (Sao Paulo). 2017 Apr;72(4):244-253. doi: 10.6061/clinics/2017(04)09. Clinics (Sao Paulo). 2017. PMID: 28492725 Free PMC article. Review.
Developing countries have limited healthcare resources and use different strategies to diagnose breast cancer. Most of the population depends on the public healthcare system, which affects the diagnosis of the tumor. ...A systematic review and the Population, …
Developing countries have limited healthcare resources and use different strategies to diagnose breast cancer. Most of the pop …
Supplemental Breast Cancer Screening in Women with Dense Breasts and Negative Mammography: A Systematic Review and Meta-Analysis.
Hussein H, Abbas E, Keshavarzi S, Fazelzad R, Bukhanov K, Kulkarni S, Au F, Ghai S, Alabousi A, Freitas V. Hussein H, et al. Radiology. 2023 Mar;306(3):e221785. doi: 10.1148/radiol.221785. Epub 2023 Jan 31. Radiology. 2023. PMID: 36719288
Background The best supplemental breast cancer screening modality in women at average risk or intermediate risk for breast cancer with dense breast and negative mammogram remains to be determined. Purpose To conduct systematic review and …
Background The best supplemental breast cancer screening modality in women at average risk or intermediate risk for …
The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.
Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. Youlden DR, et al. Cancer Epidemiol. 2012 Jun;36(3):237-48. doi: 10.1016/j.canep.2012.02.007. Epub 2012 Mar 27. Cancer Epidemiol. 2012. PMID: 22459198 Free article. Review.
BACKGROUND: This paper presents the latest international descriptive epidemiological data for invasive breast cancer amongst women, including incidence, survival and mortality, as well as information on mammographic screening programmes. ...Observed improveme …
BACKGROUND: This paper presents the latest international descriptive epidemiological data for invasive breast cancer amongst w …
32,755 results
You have reached the last available page of results. Please see the User Guide for more information.